Bertrand William C JR

CIK 00012919376 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001291937

Recent Transactions

50 trades

Award
ARDELYX, INC.$ARDX
Common Stock
2026-06-16+12,345→ 303,052 total
Award
ARDELYX, INC.$ARDX
Common Stock
2026-06-16+26,455→ 329,507 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-06-16+39,715→ 39,715 total
Sale
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of GBP0.001 per share
2025-08-28$0.01/sh−207,000→ 986,352 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+41,551→ 290,707 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+19,390→ 249,156 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-06-18+54,059→ 54,059 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2025-02-20+1,074,696→ 1,074,696 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2025-02-20+1,612,032→ 1,612,032 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2025-01-17$0.58/sh−5,584→ 7,510 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2025-01-15$0.57/sh−9,803→ 13,756 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2025-01-13$0.59/sh−4,268→ 5,845 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2025-01-13$0.59/sh−5,471→ 7,623 total
Award
ARDELYX, INC.$ARDX
Common Stock
2024-06-14+11,023→ 229,766 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2024-06-14+40,243→ 40,243 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2024-01-17$0.67/sh−5,309→ 7,785 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2024-01-17$0.67/sh−13,599→ 20,201 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2024-01-16$0.79/sh−4,681→ 7,023 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2024-01-15+2,544,432→ 2,544,432 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2024-01-15+565,416→ 565,416 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2024-01-12$0.85/sh−5,220→ 7,874 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2024-01-11$0.84/sh−4,009→ 6,104 total
Award
ARDELYX, INC.$ARDX
Common Stock
2023-06-15+16,581→ 218,743 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2023-06-15+49,237→ 49,237 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2023-01-17+202,800→ 202,800 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2023-01-17+1,407,072→ 1,407,072 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2023-01-17+314,256→ 314,256 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2023-01-17$1.86/sh−4,440→ 7,264 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2023-01-12$1.71/sh−4,973→ 8,121 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2023-01-11$1.75/sh−3,843→ 6,270 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2023-01-04$1.69/sh−3,584→ 5,781 total
Award
ARDELYX, INC.$ARDX
Common Stock
2022-06-15+118,613→ 202,162 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2022-06-15+100,000→ 100,000 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2022-01-18$3.19/sh−4,368→ 7,336 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2022-01-12+314,256→ 314,256 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2022-01-12+1,407,072→ 1,407,072 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2022-01-12$3.54/sh−2,248→ 3,754 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2022-01-11$3.56/sh−3,770→ 6,343 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2022-01-04$4.06/sh−3,490→ 5,873 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2021-07-02$4.26/sh−4,375→ 7,329 total
Award
ARDELYX, INC.$ARDX
Common Stock
2021-06-16+8,891→ 83,549 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2021-06-16+32,765→ 32,765 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2021-01-12$6.15/sh−2,234→ 3,768 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2021-01-11+1,086,816→ 1,086,816 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2021-01-11+242,712→ 242,712 total
Sale
Adaptimmune Therapeutics PLC$ADAP
American Depositary Shares representing Ordinary Shares
2021-01-04$5.33/sh−3,499→ 5,864 total
Award
ARDELYX, INC.$ARDX
Common Stock
2020-12-14$7.08/sh+15,000→ 74,658 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of GBP0.001 per share
2020-12-14$0.69/sh+207,000→ 284,808 total
Award
ARDELYX, INC.$ARDX
Common Stock
2020-06-09+7,523→ 59,658 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2020-06-09+23,500→ 23,500 total

Companies

Recent Filings

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451

View on SEC.gov